WHO ICTRP trial
A study in male and female patients with neurogenic detrusor overactivity due to…
EUCTR2017-000905-19-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2017-000905-19-FR |
|---|---|
| Public title | A study in male and female patients with neurogenic detrusor overactivity due to spinal cord injury to evaluate the effects of two different doses of REC 0/0438 administered by intra-vesical injection. |
| Scientific title | EFFECTS OF TWO DIFFERENT DOSES OF REC 0/0438 ADMINISTERED BY INTRA-VESICAL INSTILLATION IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY DUE TO SPINAL CORD INJURY: A REPEATED DOSES, DOUBLE-BLIND, PLACEBO CONTROLLED STUDY |
| Primary sponsor | Recordati S.p.A |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): yes Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | Portugal;France;Czech Republic |
| Conditions | neurogenic detrusor overactivity due to spinal cord injury MedDRA version: 20.0 Level: LLT Classification code 10005059 Term: Bladder neurogenic System Organ Class: 100000004857 ;Therapeutic area: Not possible to specify |
| Interventions | Product Code: Rec 0/0438 Pharmaceutical Form: Powder for intravesical solution INN or Proposed INN: - CAS Number: 905985-64-0 Current Sponsor code: REC 0/0438 Concentration unit: mg milligram(s) Concentration type: equal Concentration… |
| Registration date | Dec 27, 2017 |
| Target size | 36 |
| Secondary IDs | Rec0/0438-IT-CL0491;2017-000905-19-PT |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: